Wladimir Hogenhuis serves as Executive at Ultragenyx Pharmaceutical Inc., where they oversee executive responsibilities. Since joining the company, Wladimir Hogenhuis has executed 9 insider transactions totaling $194.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 16, 2025 involved purchasing 5,650 shares valued at $9.5K.
Wladimir Hogenhuis currently holds 119,675 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wladimir Hogenhuis has been a net buyer of RARE stock. They have purchased $194.6K and sold $0 worth of shares.
Wladimir Hogenhuis's most recent insider trade was on Dec 16, 2025, when they purchased 5,650 shares at $1.69 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 24, 2024 | RZLT | $20.0K | Purchase | 4,259 | $4.70 | Discretionary |
| Jun 25, 2024 | RZLT | $20.0K | Purchase | 4,815 | $4.15 | Discretionary |
| May 4, 2022 | RZLT | $95.0K | Purchase | 25,000 | $3.80 | Discretionary |
| Oct 15, 2021 | RZLT | $50.0K | Purchase | 7,693 | $6.50 | Discretionary |
| Oct 4, 2019 | RARE | $57.7K | Payment | 1,297 | $44.52 | Discretionary |
| Mar 1, 2019 | RARE | $0 | Award | 5,000 | $N/A | Discretionary |
| Oct 4, 2018 | RARE | $0 | Award | 15,000 | $N/A | Discretionary |